( IDIBELL-Bellvitge Biomedical Research Institute ) Experts from the Institute of Neurosciences of the University of Barcelona, the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Advanced Chemistry of Catalonia (IQAC) from CSIC, are designing the first light-operated drug to treat pain

Read the source article at EurekAlert! Science News

Please Support NAALT and make a Tax Deductible Donation. We're now a 501(c)(3) Corporation!

Go to top